HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenneth Newman Selected Research

ensifentrine

10/2019Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma.
11/2018The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenneth Newman Research Topics

Disease

4Asthma (Bronchial Asthma)
10/2019 - 06/2002
3Inflammation (Inflammations)
11/2005 - 07/2003
2Pain (Aches)
01/2005 - 12/2004
2Postoperative Pain
01/2005 - 12/2004
1Chronic Obstructive Pulmonary Disease (COPD)
11/2018
1Airway Remodeling
11/2005
1Acute Pain
01/2005
1Wounds and Injuries (Trauma)
01/2005
1Pneumonia (Pneumonitis)
07/2003

Drug/Important Bio-Agent (IBA)

3flunisolide (AeroBid)FDA LinkGeneric
11/2005 - 06/2002
2Bronchodilator Agents (Bronchodilators)IBA
10/2019 - 11/2018
2Albuterol (Salbutamol)FDA LinkGeneric
10/2019 - 11/2018
2ensifentrineIBA
10/2019 - 11/2018
2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
10/2019 - 11/2018
2apaflurane (hydrofluoroalkane)IBA
11/2005 - 07/2003
2Ibuprofen (Motrin)FDA LinkGeneric
01/2005 - 12/2004
2Oxycodone (Oxycontin)FDA LinkGeneric
01/2005 - 12/2004
1Ipratropium (Ipratropium Bromide)FDA LinkGeneric
11/2018
1CollagenIBA
11/2005
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2005
1Transforming Growth Factor beta (TGF-beta)IBA
11/2005
1Pharmaceutical PreparationsIBA
01/2005
1Analgesics (Analgesic Drugs)IBA
01/2005
1GlucocorticoidsIBA
07/2003
1Beclomethasone (Beclometasone)FDA Link
06/2002
1Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric
06/2002

Therapy/Procedure

1Therapeutics
01/2005